Clinical Trials Logo

Proteinuria clinical trials

View clinical trials related to Proteinuria.

Filter by:

NCT ID: NCT03190694 Completed - Clinical trials for Chronic Kidney Diseases

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

DIAMOND
Start date: November 12, 2017
Phase: Phase 2
Study type: Interventional

This study tests the hypothesis that dapagliflozin lowers proteinuria in patients with non-diabetic chronic kidney disease.

NCT ID: NCT03155919 Completed - Clinical trials for Athletic Proteinuria

Taurine Supplementation and Triathletes

Start date: February 2014
Phase: N/A
Study type: Interventional

Taurine is a nitrogenous compound, naturally present in heart, leukocytes, retina, central nervous system, especially in muscles. It has several beneficial physiological effects like antioxidant action, and could increase muscle force contraction and insulin sensibility. Triathlon is a sport of medium to high intensity, that can causes an increase in the rate of oxygen consumption during intense exercise and consequently increases free radicals production and oxidative stress, which may compromise an athlete's performance. Due to the weekly intense training, triathletes need nutritional care ranging from calories and nutrients adequacy to the use of specific nutrients that can help to maintain health. Thus, it is believed that the use of taurine associated with chocolate milk after exercise can promote general metabolic insulin action in order to favor carbohydrates metabolism regulation, assist muscle recover and prevent oxidative damage and thus promote triathletes performance and muscle mass gain. Thus, the aim of this project is to evaluate the effects of taurine and chocolate milk supplementation in body composition, athletic performance and oxidative stress in triathletes.

NCT ID: NCT03149068 Not yet recruiting - Clinical trials for Evaluation of Early Inflammatory Process in CKD

Studying the Relationship Between Mean Platelet Volume and Neutrophil/ Lymphocyte Ratio With Inflammation and Proteinuria in Chronic Kidney Disease

Start date: July 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Inflammation begins during early stages of CKD in which neutrophil counts are increased, whereas lymphocyte counts are decreased during inflammation. In addition to known conventional indications of inflammation such as C-reactive protein (CRP), fibrinogen, erythrocyte sedimentation rate, several interleukins and tumor necrotizing factor alpha, Neutrophil-to-lymphocyte ratio (NLR) has increasingly been reported as a measure of systemic inflammation (Okyay G U et al 2013 and Yilmaz G et al ,2017) Several recent studies have shown that mean platelet volume (MPV) is also increased during inflammation and may be associated with poorer prognosis in CKD (Yilmaz G et al ,2017).

NCT ID: NCT03019848 Recruiting - Proteinuria Clinical Trials

Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease

Start date: May 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if the oral supplementation with curcumin reduces proteinuria, improves the redox and pro-inflammatory state in patients with chronic kidney disease associated to Diabetes mellitus.

NCT ID: NCT03015974 Recruiting - IgA Nephropathy Clinical Trials

Registry of IgA Nephropathy in Chinese Children

RACC
Start date: January 2016
Phase:
Study type: Observational [Patient Registry]

This study tries to identify the safe and effective treatment option for IgA nephropathy in children. Investigators will perform prospective registration study among 25 pediatric nephrology medical centers in China.

NCT ID: NCT02973178 Recruiting - Clinical trials for Urinary Tract Infections

Scanadu Urine Device Validation Study Protocol

Start date: August 2016
Phase: N/A
Study type: Interventional

This study will test Scanadu Urine Device for clinical performance and usability.

NCT ID: NCT02972346 Recruiting - Proteinuria Clinical Trials

Availability Study of ACTH to Treat Children SRNS/SDNS

Start date: November 2016
Phase: N/A
Study type: Interventional

Primary nephrotic syndrome(NS) is a common children renal disease.About 20% primary nephrotic syndrome are steroid-dependent and steroid-resistant.Low serum cortisol is one of the main relapse reasons.Adrenocorticotropic hormone(ACTH)-induced steroidogenesis improve serum cortisol and also direct melanocortin receptors(MCRs) mediated protective effect on kidney cells. To investigate the efficacy and safety of ACTH to treat NS, total 42 children steroid resistant or steroid dependent NS is enrolling in this multicenter, prospective case series of prescription based treatment with ACTH for NS.

NCT ID: NCT02882373 Withdrawn - Hypertension Clinical Trials

Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Start date: October 23, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well arginine works in treating patients with kidney injury caused by anti-VEGF drugs used in standard treatment for cancer. Arginine is a nutritional supplement that may control side effects of anti-cancer drugs such as high blood pressure and protein in the urine and may also help to improve kidney function in patients.

NCT ID: NCT02818192 Recruiting - Type 2 Diabetes Clinical Trials

Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)

iCARE
Start date: January 2017
Phase:
Study type: Observational

The overall aim of the project is to elucidate the primary bio-psycho-social (BPS) risk factors for albuminuria in youth with type 2 diabetes (T2D) and the mechanisms by which they cause renal injury. The Study aims include: 1. Characterize the primary BPS risk factors associated with prevalent and progressive albuminuria in youth with T2D. 2. Determine individual, family and community level factors that influence biological and psychological risk factors and behaviors (adherence) that could be modified to protect against prevalent and progressive albuminuria. 3. Determine if systemic and renal inflammation is the common pathway through which BPS risk factors lead to albuminuria in youth with T2D. Study Hypotheses include: 1. Biological factors (poor glycemic control and systolic ambulatory hypertension), and psychological and social adversity (stress, mental distress and poverty) are significant predictors of prevalent and progressive albuminuria in youth with T2D. 2. Community and family support will be negatively associated with stress, and a lower risk of both prevalent and progressive albuminuria. 3. Systemic and renal inflammation is the common pathway through which BPS risk factors lead to albuminuria in youth with T2D.

NCT ID: NCT02798042 Recruiting - Obesity Clinical Trials

Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?

Start date: June 16, 2016
Phase:
Study type: Observational

Acute kidney injury (AKI) is a common, but significant complication after elective surgery which is associated with an increased risk of mortality, major adverse cardiac events, prolonged length of hospital stay, and increased cost per episode of care.